Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2012
07/11/2012CN102574817A Aminoquinazoline compounds for combating invertebrate pests
07/11/2012CN102574816A Potent small molecule inhibitors of autophagy, and methods of use thereof
07/11/2012CN102574815A Mesoionic pesticides
07/11/2012CN102574813A Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
07/11/2012CN102574812A New benzimidazole derivatives and their use as fxr agonists
07/11/2012CN102574805A Novel quinoline-hepcidine antagonists
07/11/2012CN102574804A Quinolinyloxyphenylsulfonamides
07/11/2012CN102574797A Benzo[k]fluoranthene derivative and organic electroluminescence element containing same
07/11/2012CN102574789A Pyrrolidinone carboxamide derivatives as chemerin-R ( CHEMR23 ) modulators
07/11/2012CN102574786A Dihydroorotate dehydrogenase inhibitors
07/11/2012CN102574785A Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators
07/11/2012CN102573838A Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
07/11/2012CN102558417A Polymer and preparation method thereof for solution process OLED
07/11/2012CN102558231A Ophthalmic compositions for treating ocular hypertension
07/11/2012CN102558173A Compound inhibiting conduction of WNT signal, and composition and application thereof
07/11/2012CN102558157A Ethoxyl-triazole compound or amonoethyl-triazole compound and preparation method and application thereof
07/11/2012CN102558155A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
07/11/2012CN102558154A Lansoprazole crystalline compound, enteric capsule thereof and preparation method of Lansoprazole crystalline compound
07/11/2012CN102558153A Novel pharmaceutical salt of dabigatran etexilate and preparation method thereof
07/11/2012CN102558152A Preparation method of 4-[(3-methylene pyridine)-amino]-6-methyl-4,5-dihydro-2H-[1,2,4] triazole-3-ketone
07/11/2012CN102558151A Application of trivalent iodine ligand to synthesis of chiral sulfoxide compound
07/11/2012CN102558150A Synthesis process for sulfoxide substituted compound
07/11/2012CN102558149A Pyrimidine derivative, preparation method thereof, medicinal composition and application thereof
07/11/2012CN102558148A Synthesis process of lansoprazole important intermediate
07/11/2012CN102558147A Compound, and preparation method and application thereof
07/11/2012CN102558146A 1-N-substituent-6-pyrazol methylene chinoline-4-ketone-3-formic acid compound, and preparation method and application thereof
07/11/2012CN102558145A Method for preparing balofloxacin
07/11/2012CN102558144A Aryl urea derivatives
07/11/2012CN102558075A Substituted piperazines as CB1 antagonists
07/11/2012CN102558058A 1-aryl-3-substituent-5-substituted amino-4-pyrazole formamide compound and application thereof
07/11/2012CN102558023A Organic light-emitting device
07/11/2012CN102552178A Lyophilized powder injection of rabeprazole sodium medicinal composition and preparation method of lyophilized powder injection
07/11/2012CN101353344B Pyrazolyl-substituted heterocycles and their use as phytosanitary products
07/10/2012US8217179 Preparation method of phenylcarboxamides
07/10/2012US8217178 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-flouro-1-(2-methoxy-ethyl)-4-trifluorom as an inhibitor of mast cell tryptase
07/10/2012US8217173 Fluoride-releasing compositions
07/10/2012US8217172 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea
07/10/2012US8217171 Antiviral agents
07/10/2012US8217170 Process for the preparation of tertiary N-allyl sterically hindered amines
07/10/2012US8217168 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptors
07/10/2012US8217067 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/10/2012US8217057 Polymorphs of a c-MET/HGFR inhibitor
07/10/2012US8217052 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
07/10/2012US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/10/2012US8217045 Organic compounds
07/10/2012US8217044 Spiroindolinone pyrrolidines
07/10/2012US8217038 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
07/10/2012US8217029 Oxazolidinone antibiotics
07/10/2012CA2658334C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
07/10/2012CA2566461C Pyrrole compounds as inhibitors of erk protein kinase, synthesis thereof and intermediates thereto
07/10/2012CA2564062C Indole derivative having piperidine ring
07/10/2012CA2559711C Nuclear magnetic resonance assembly of chemical entities using advanced antenna probes
07/10/2012CA2553269C Quinoline derivatives and use thereof as mycobacterial inhibitors
07/10/2012CA2551171C Modulators of peripheral 5-ht receptors
07/10/2012CA2545942C Aryl imidazoles and their use as anti-cancer agents
07/10/2012CA2543820C Methods for synthesizing quinolinone compounds
07/10/2012CA2540647C Tetrahydro-naphthalene and urea derivatives
07/10/2012CA2536658C Chemiluminescent compounds
07/10/2012CA2526430C Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
07/10/2012CA2520893C Process for the preparation of 1-n-(phenyl)-2-n-(phenyl)pyrrolidine-1,2-dicarboxamide derivatives and 1-(phenylcarbamoyl)pyrrolidine-2-carboxylic acid derivatives as intermediates
07/10/2012CA2513463C Gyrase inhibitors and uses thereof
07/10/2012CA2507381C Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
07/10/2012CA2505195C Quinazolinones as potassium channel modulators
07/10/2012CA2481369C Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
07/10/2012CA2470427C Compositions and methods for treating heart failure
07/10/2012CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents
07/10/2012CA2417311C Crystalline alkali metal salts of lansoprazole and their production and use
07/05/2012WO2012092411A2 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
07/05/2012WO2012092367A1 Nucleic acid binding compounds, methods of making, and use thereof
07/05/2012WO2012091026A1 1,3,5-triazine compound, method for preparing same, and organic electroluminescent element comprising same
07/05/2012WO2012090221A1 Novel salts of imatinib
07/05/2012WO2012090179A2 Isoquinoline derivatives as cannabinoid receptor modulators
07/05/2012WO2012090177A2 Cannabinoid receptor modulators
07/05/2012WO2012089828A2 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012WO2012089757A1 Fungicide hydroximoyl-tetrazole derivatives
07/05/2012WO2012089633A1 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
07/05/2012WO2012089607A1 Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors
07/05/2012WO2012089137A1 Arylurea compound, intermediate and use thereof
07/05/2012WO2012064943A3 Metalloenzyme inhibitor compounds
07/05/2012WO2012064744A3 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
07/05/2012WO2012037498A3 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
07/05/2012WO2012037411A3 Estrogen receptor modulators and uses thereof
07/05/2012WO2012031220A3 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
07/05/2012WO2011110876A8 Novel salts for the manufacture of pharmaceutical compositions
07/05/2012US20120172593 Meta-stable state nitrogen-containing polymer
07/05/2012US20120172582 Labelling Strategies for the Sensitive Detection of Analytes
07/05/2012US20120172397 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
07/05/2012US20120172384 Heterocyclylaminopyrimidines as kinase inhibitors
07/05/2012US20120172382 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
07/05/2012US20120172378 Novel compounds
07/05/2012US20120172376 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012US20120172372 Ureas and Their Use in the Treatment of Heart Failure
07/05/2012US20120172368 Bis-Benzimidazole Derivatives
07/05/2012US20120172358 GPCR Agonists
07/05/2012US20120172354 Substituted N-Phenyl-1-(4-Pyridinyl)-1H-Pyrazol-3-Amines
07/05/2012US20120172349 Therapeutic compounds and compositions
07/05/2012US20120172217 Pesticidal compositions
07/05/2012US20120171730 Method and substances for preparation of n-substituted pyridinium compounds
07/05/2012US20120171665 Fluorescent markers and use thereof for labeling specific protein targets
07/05/2012US20120171183 Arthropodicidal anthranilamides
1 ... 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 ... 1080